ClinicalTrials.gg
CompletedNCT03642444Updated Aug 22, 2018

Replacing Canes With an Elasticated Orthosis in Chronic Stroke Patients: The Influence on Gait and Balance. A Series of N-of-1 Trials

An interventional study of Cane and Elasticated worn orthotic-garment in Stroke, sponsored by Technical University of Bern. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-08-22.

Sponsored by Technical University of Bern · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was Oct 2014, 12 years 1 month ago, and no results have been posted to the registry.
  • Registered 4 years 7 months after the study started (first participant enrolled Jan 2014, registered Aug 2018).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to investigate the effect of an elasticated orthotic garment "Thera Togs" on walking ability and balance in currently cane using chronic stroke subjects (minimum 6 months post stroke) using a series of N-of-1 Trials.

Read the detailed description

Aim: To investigate the effect of replacing canes with an elasticated orthotic-garment on gait and balance in chronic stroke subjects.

Design Experimental, multiple baseline N-of-1 series with an ABC design with randomised period duration.

Participants Four cane using chronic stroke subjects. Interventions Phase A (9-12 weeks) usual cane-walking to establish baseline values; Phase B (9-19 weeks) intervention: orthotic-garment worn throughout the day with maximal cane reduction; Phase C (9-10 weeks) individually determined follow-up: either no walking-aid, orthotic-garment or cane.

Weekly measurement of Outcome Measures for gait and balance function

02

Conditions studied

  • Stroke

Keywords

  • stroke
  • hemiplegia
03

In context

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

This study's enrollment of 4 is below the median of 48 across 6,049 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Technical University of Bern is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Chronic stroke (> six months since last stroke)
  • Independent cane walkers. Subjects usually use canes to walk inside (this could be intermittent changing from cane to holding furniture etc.) and always when outside
  • A Mini Mental Score of 22 or above.

Exclusion criteria

Exclusion Criteria:

  • Patients at risk of falling identified as a Berg Balance Score ≤42/56
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
4 participants (actual)

Study arms

  • Active comparator
    Phase A cane walking (assistive walking-device a cane)

    9-12 weeks usual cane-walking to establish baseline values. Patients walk with their usual assistive-walking device - a cane.

    Device: Cane

  • Active comparator
    Phase B elasticated orthotic-garment - TheraTogs

    9-19 weeks : assistive walking-device which is an elasticated orthotic-garment worn throughout the day (product name TheraTogs). Cane use maximally reduced during his period.

    Device: Elasticated worn orthotic-garment

  • No intervention
    Phase C follow-Up

    9-10 weeks individually determined follow-up: subjects determine whether they walk independently (without assistive device) or with the elasticated orthotic-garment (TheraTogs) or with a cane.

Interventions

  • DeviceCane

    Assistive walking device

  • DeviceElasticated worn orthotic-garment

    Assistive walking device -elasticated worn orthotic garment

    Also known as: TheraTogs (product name)

06

What researchers measure

Primary outcomes

  1. Change in Functional Gait Assessment from baseline to post-Intervention (up to 28 weeks)

    Change of gait function between phases A (baseline) and Phase B (Intervention)

    Time frame: Post intervention up to 28 weeks (on average 21.5 weeks)

Secondary outcomes

  1. Change in Trunk-sway from baseline to post-Intervention (up to 28 weeks)

    Change of trunk-sway at body center-of-mass during walking measured as Total-Angle-Area(TAA°) in frontal and sagittal-planes measured with a gyroscope "Sway Star" between phases A (baseline) and Phase B (Intervention)

    Time frame: Post intervention up to 28 weeks (on average 21.5 weeks)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Maguire CC, Sieben JM, Lutz N, van der Wijden G, Scheidhauer H, de Bie R. Replacing canes with an elasticated orthotic-garment in chronic stroke patients - The influence on gait and balance. A series of N-of-1 trials. J Bodyw Mov Ther. 2020 Oct;24(4):203-214. doi: 10.1016/j.jbmt.2020.06.006. Epub 2020 Jul 30. PubMed 33218513 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2014 to primary completion in Oct 2014, 9 months.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 9 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2018
First posted
Aug 22, 2018
StartActual
Jan 8, 2014
Primary completionActual
Oct 15, 2014
CompletionActual
Jan 30, 2015
Last update
Aug 22, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03642444
Lead sponsor
Technical University of Bern
Collaborators
Bildungszentrum Gesundheit Basel-Stadt, Rehab Basel
Responsible party
Clare Maguire (Principle Investigator, Technical University of Bern) — Principal investigator
First posted
Aug 22, 2018
Start date
Jan 8, 2014
Primary completion
Oct 15, 2014
Completion
Jan 30, 2015
Last update
Aug 22, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion